ANTIVIRAL PHOSPHINATE COMPOUNDS

PROBLEM TO BE SOLVED: To provide phosphinate compounds with HCV inhibitory activity.SOLUTION: The invention is related to anti-viral phosphinate compounds, compositions containing the compounds, and treatment methods that include administering the compounds, as well as to methods and intermediates u...

Full description

Saved in:
Bibliographic Details
Main Authors WANG JIANYING, CHO AESOP, FARDIS MARIA, CLARKE MICHAEL, KIM CHOUNG U, DOERFFLER EDWARD, PYUN HYUNGJUNG, CASAREZ ANTHONY, CHAUDHARY KLEEM, SHENG XIAONING C
Format Patent
LanguageEnglish
Japanese
Published 30.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PROBLEM TO BE SOLVED: To provide phosphinate compounds with HCV inhibitory activity.SOLUTION: The invention is related to anti-viral phosphinate compounds, compositions containing the compounds, and treatment methods that include administering the compounds, as well as to methods and intermediates useful for producing the compounds. The compositions of the invention are useful in treating disorders associated with the HCV. In one embodiment, the invention also provides a pharmaceutical composition further containing a nucleoside analogue. The invention provides a pharmaceutical composition further containing an interferon or pegylated interferon. 【課題】HCV阻害活性を持つホスフィナート化合物の提供。【解決手段】本発明は、抗ウィルスホスフィナート化合物、該化合物を含む組成物、および該化合物を投与することを含む処置方法、ならびに、該化合物の製造に有用な方法および中間体に関する。本発明の組成物は、例えば、HCVに関連する障害の処置において有用である。一実施形態において、また本発明は、さらにヌクレオシド類縁体を含む医薬組成物も提供する。また本発明は、さらにインターフェロンまたはペグ化インターフェロンを含む医薬組成物も提供する。【選択図】なし
Bibliography:Application Number: JP20150010367